Advanced search
Publication Cover
Cancer Biology & Therapy Volume 18, 2017 - Issue 12
Submit an article Journal homepage
983
Views
7
CrossRef citations to date
0
Altmetric
Bedside to Bench Report

Sequential occurrence of small cell and non-small lung cancer in a male patient: Is it a transformation?

Ahsan WahabInternal Medicine Department, McLaren – Flint/Michigan State University, Flint, MI, USACorrespondence[email protected]
,
Kavitha KesariInternal Medicine Department, McLaren – Flint/Michigan State University, Flint, MI, USA
,
Siddique ChaudharyInternal Medicine Department, McLaren – Flint/Michigan State University, Flint, MI, USA
,
Mahin KhanInternal Medicine Department, McLaren – Flint/Michigan State University, Flint, MI, USA
,
Hafiz KhanInternal Medicine Department, McLaren – Flint/Michigan State University, Flint, MI, USA
,
Susan SmithInternal Medicine Department, McLaren – Flint/Michigan State University, Flint, MI, USA
&
Yanis BoumberDepartment of Hematology/Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA;Program in Molecular Therapeutics, Fox Chase Cancer Center, Philadelphia, PA, USA
 show all
Pages 940-943 | Received 07 Jul 2017, Accepted 15 Oct 2017, Published online: 20 Nov 2017

References

  • Navada S, Lai P, Schwartz A, Kalemkerian G. Temporal trends in small cell lung cancer: analysis of the national Surveillance, Epidemiology, and End-Results (SEER) database. J Clin Oncol. 2006;24(18_suppl):7082–7082.
  • Yang JC, Wu YL, Schuler M, Sebastian M, Popat S, Yamamoto N, Zhou C, Hu CP, O'Byrne K, Feng J, et al. Afatinib versus cisplatin-based chemotherapy for EGFR mutation-positive lung adenocarcinoma (LUX-Lung 3 and LUX-Lung 6): analysis of overall survival data from two randomised, phase 3 trials. Lancet Oncol. 2015 Feb 28;16(2):141–51. doi:10.1016/S1470-2045(14)71173-8.
  • NCCN guidelines. Accessed March 9, 2017, at https://www.nccn.org/professionals/physician_gls/pdf/nscl.pdf.
  • Sequist LV, Waltman BA, Dias-Santagata D, Digumarthy S, Turke AB, Fidias P, Bergethon K, Shaw AT, Gettinger S, Cosper AK, et al. Genotypic and histological evolution of lung cancers acquiring resistance to EGFR inhibitors. Sci Transl Med. 2011;3(75):75ra26. doi:10.1126/scitranslmed.3002003.
  • Kuiper JL, Heideman DA, Thunnissen E, Paul MA, Van Wijk AW, Postmus PE, Smit EF. Incidence of T790M mutation in (sequential) rebiopsies in EGFR-mutated NSCLC-patients. Lung cancer. 2014 Jul 31;85(1):19–24. doi:10.1016/j.lungcan.2014.03.016.
  • Goss G, Tsai CM, Shepherd FA, Bazhenova L, Lee JS, Chang GC, Crino L, Satouchi M, Chu Q, Hida T, et al. Osimertinib for pretreated EGFR Thr790Met-positive advanced non-small-cell lung cancer (AURA2): a multicentre, open-label, single-arm, phase 2 study. Lancet Oncol. 2016 Dec 31;17(12):1643–52. doi:10.1016/S1470-2045(16)30508-3.
  • Alì G, Bruno R, Giordano M, Prediletto I, Marconi L, Zupo S, Fedeli F, Ribechini A, Chella A, Fontanini G. Small cell lung cancer transformation and the T790M mutation: A case report of two acquired mechanisms of TKI resistance detected in a tumor rebiopsy and plasma sample of EGFR-mutant lung adenocarcinoma. Oncol Lett. 2016;12(5):4009–4012.
  • Piotrowska Z, Niederst MJ, Karlovich CA, Wakelee HA, Neal JW, Mino-Kenudson M, Fulton L, Hata AN, Lockerman EL, Kalsy A, et al. Heterogeneity underlies the emergence of EGFRT790 wild-type clones following treatment of T790M-positive cancers with a third-generation EGFR inhibitor. Cancer Discov. 2015 Jul 1;5(7):713–22. doi:10.1158/2159-8290.CD-15-0399.
  • Niederst MJ, Sequist LV, Poirier JT, Mermel CH, Lockerman EL, Garcia AR, Katayama R, Costa C, Ross KN, Moran T, et al. RB loss in resistant EGFR mutant lung adenocarcinomas that transform to small-cell lung cancer. Nat Commun 2015 Mar 11;6:6377. doi:10.1038/ncomms7377.
  • Fujita K, Kim YH, Yoshizawa A, Mio T, Mishima M. Concomitant T790M mutation and small‐cell lung cancer transformation after acquired resistance to epidermal growth factor receptor‐tyrosine kinase inhibitor. Respirol Case Rep. 2017;5(1):e00206.
  • Suda K, Murakami I, Sakai K, Mizuuchi H, Shimizu S, Sato K, Tomizawa K, Tomida S, Yatabe Y, Nishio K, et al. Small cell lung cancer transformation and T790M mutation: complimentary roles in acquired resistance to kinase inhibitors in lung cancer. Sci Rep. 2015 Sep 24;5:14447. doi:10.1038/srep14447.
  • Furugen M, Uechi K, Hirai J, Aoyama H, Saio M, Yoshimi N, Kinjo T, Miyagi K, Haranaga S, Higa F, et al. An autopsy case of two distinct, acquired drug resistance mechanisms in epidermal growth factor receptor-mutant lung adenocarcinoma: small cell carcinoma transformation and epidermal growth factor receptor T790M mutation. Intern Med. 2015;54(19):2491–6. doi:10.2169/internalmedicine.54.5481.
  • Miyoshi Y, Uemura H, Kitami K, Satomi Y, Kubota Y, Hosaka M. Neuroendocrine differentiated small cell carcinoma presenting as recurrent prostate cancer after androgen deprivation therapy. BJU Int. 2001;88(9):982–983.
  • Ahn S, Hwang SH, Han J, Choi YL, Lee SH, Ahn JS, Park K, Ahn MJ, Park WY. Transformation to small cell lung cancer of pulmonary adenocarcinoma: clinicopathologic analysis of six cases. J Pathol Transl Med. 2016 Jul;50(4):258. doi:10.4132/jptm.2016.04.19.
  • Oser MG, Niederst MJ, Sequist LV, Engelman JA. Transformation from non-small-cell lung cancer to small-cell lung cancer: molecular drivers and cells of origin. Lancet Oncol. 2015;16(4):e165-e172. doi:10.1016/S1470-2045(14)71180-5.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.